A new study shows that the mouth may be a more sensitive reflection of the body's metabolic status than the scale. Scientists have found that obese people have a completely different oral microbiome than healthy-weight people.This discovery shifts the focus of research from traditional intestinal flora to the oral cavity, suggesting that oral microorganisms may become an important biomarker for monitoring metabolic health, and is expected to change our traditional understanding of how to detect obesity-related biological indicators.
Obesity is a chronic, relapsing disease affected by diet, genetics and lifestyle, affecting hundreds of millions of people worldwide. Although previous research on the biological basis of obesity has mainly focused on the dense microbial ecosystem of the gut, the potential link between oral microbes and obesity has received less attention. A new study recently published in Cell Reports fills this gap. Researchers at New York University Abu Dhabi analyzed saliva samples from 628 adults and found that the oral microbiome of obese patients is not only different from ordinary people in the composition of bacterial species, but also has significant differences in the active functions of their microorganisms.
In order to delve deeper, the research team did not stop at a simple classification of microbial species, but further analyzed the gene activities within the oral flora, that is, focusing on what these bacteria are "doing". The results show that the oral ecosystem is not a passive background, but can reflect systemic health through metabolic activity. In obese participants, bacterial pathways associated with sugar fermentation and lactic acid production were more active, while the ability to produce certain essential nutrients was reduced. Data show that body mass index (BMI) is one of the strongest factors driving variation in the oral microbiome, suggesting that the oral microbiome reflects a broader metabolic state.
The study points out that these changes have clear metabolic implications. Species related to inflammation and lactate production were more prominent in obese people, such as the pro-inflammatory Streptococcus parasanguinis and Actinomyces oris, and the lactate-producing Oribacterium sinus; at the same time, species related to nutrient synthesis were reduced. This metabolic reorganization is profound: 94 metabolic pathways differ between the two groups, mainly involving carbohydrate breakdown, amino acid metabolism, and the production of small signaling molecules. The most obvious example is the way oral microbes process sugar - genes involved in the production of lactate, which is known to be closely linked to insulin resistance and cardiometabolic stress, are more active in obese individuals. In addition, levels of metabolites that affect appetite and energy balance, such as uridine and uracil, are increased, while pathways responsible for the synthesis of specific B vitamins are less active.
The researchers emphasize that these findings are not limited to microbial sequencing. By combining microbiome data with salivary metabolomics and clinical blood markers, they found that several altered microbial pathways were associated with triglycerides, liver enzymes and other cardiometabolic markers. When the researchers incorporated oral microbiome data into the predictive model, the model's ability to differentiate between obese and healthy-weight individuals improved significantly.
However, because this study is a cross-sectional study, it is not yet possible to determine whether these microbial changes are the cause of obesity or a consequence of obesity. The research team said that these patterns may reflect underlying metabolic changes rather than directly driving obesity. This is also the biggest suspense left in the study - is it cause and effect or correlation? As a next step, the team plans to conduct longitudinal studies across populations to determine whether these oral microbiome signatures precede metabolic disease. If this association is confirmed, saliva testing may become a practical and non-invasive early screening or targeted intervention tool in the future to predict the risk of weight gain, insulin resistance or cardiometabolic decline.